Genetic Predisposition Clinical Trial
Official title:
Influence of the Genetic Polymorphisms in the Effect of Caffeine on Fat Oxidation During Exercise
Genetic polymorphism on the effect of oral caffeine intake on fat oxidation during exercise has been studied in active and healthy population performing an incremental test on a cycle ergometer with 3-min stages at workloads from 30 to 70% of maximal oxygen uptake (VO2max). Participants performed this test after the ingestion of a) placebo; b) 3 mg/kg of caffeine; c) 6 mg/kg of caffeine. Fat oxidation rate during exercise was measured by indirect calorimetry. The influence of the CYP1A2 c.-163A>C, GSTP c.313A>G and PGC1a polymorphisms was evaluated to determine the effects on fat oxidation during exercise
Caffeine is a natural stimulant with well-recognized sports performance benefits. Aside its performance-enhancing effect, caffeine has the potential of increasing fat utilization during aerobic exercise at submaximal intensities, lowering-down the contribution of carbohydrate as a fuel. This property of caffeine may provoke a glycogen-sparing effect in the skeletal muscle and liver for exercise situations where carbohydrate availability may be a challenge. Additionally, the capacity of caffeine to enhance fat utilization during exercise could be of interest for improving health outcomes as it may increase the rate of change in body composition in exercise programs. Genetic factors like CYP1A2 c.-163A>C, GSTP c.313A>G and PGC1a c.1444G>A and C>T polymorphisms could be associated with the capacity for fat oxidation during exercise. To date, it is unknown if genetics increases fat oxidation and MFO in the same proportion during morning and evening exercise trials in women. For this reason, the aim of the present study was to evaluate the influence of the tCYP1A2, GSTP and PGC1a polymorphisms on the effect of caffeine on fat oxidation and MFO in active and healthy population. The authors hypothesised that genetics would increase fat oxidation and MFO during exercise and this effect would be of similar magnitude at several caffeine doses. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04746794 -
Early Detection of GEnetic Risk (EDGE)
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Recruiting |
NCT04970056 -
Pancreatic Cancer Early Detection Consortium
|
||
Not yet recruiting |
NCT06441942 -
Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome
|
||
Terminated |
NCT04119596 -
Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease
|
||
Recruiting |
NCT04141462 -
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
|
N/A | |
Completed |
NCT02826330 -
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
|
||
Recruiting |
NCT05929976 -
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
|
||
Not yet recruiting |
NCT04620278 -
Genetic Investigation of Cancer Predisposition
|
||
Active, not recruiting |
NCT02373709 -
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression
|
||
Not yet recruiting |
NCT06089421 -
Genetic Information Assistant in Telegenetics
|
N/A | |
Completed |
NCT03954652 -
Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"
|
N/A | |
Completed |
NCT04113239 -
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
|
||
Enrolling by invitation |
NCT04373525 -
Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
|
||
Completed |
NCT03362099 -
Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING)
|
Phase 4 | |
Recruiting |
NCT05857670 -
Psyco Quality of Life and Procreation BRCA1/2
|
||
Active, not recruiting |
NCT04774445 -
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
|
N/A | |
Recruiting |
NCT05759143 -
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
|
N/A | |
Active, not recruiting |
NCT04920513 -
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
|
||
Active, not recruiting |
NCT04781205 -
Genome Driven Primary Care Clinics - an RCT
|
N/A |